Motus GI touted clinical data evaluating its Pure-Vu cleaning system.
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 21, 2021 | Post-IPO Debt | $12M | 1 | Kreos Capital | — | Detail |
Dec 18, 2019 | Post-IPO Debt | $8M | 1 | Silicon Valley Bank | — | Detail |
Feb 14, 2018 | IPO | $17.50M | — | — | — | Detail |
Dec 1, 2016 | Series Unknown | $30M | 6 | Perceptive Advisors | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kreos Capital | Yes | Post-IPO Debt |
Silicon Valley Bank | Yes | Post-IPO Debt |
Perceptive Advisors | Yes | Series Unknown |
Ascent Biomedical Ventures | — | Series Unknown |
Jacobs Investments, Inc. | — | Series Unknown |
Orchestra Medical Ventures | — | Series Unknown |
Pura Vida Investments | — | Series Unknown |
SternAegis | — | Series Unknown |